Non-conventional apoptotic response to ionising radiation mediated by N-methyl D-aspartate receptors in immature neuronal cells

International Journal of Molecular Medicine

Volumn 31, Issue 3, 2013, Pages 516-524

  Samari, Nada ^a,b   De Saint Georges, Louis ^a   Pani, Giuseppe ^a   Baatout, Sarah ^a   Leyns, Luc ^b   Benotmane, Mohammed Abderrafi ^a  

^a BELGIAN NUCLEAR RESEARCH CENTRE   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Calpain; Cell death; DNA damage; Fetus; Ionising radiation; N methyl D aspartate receptor

Indexed keywords

CALCIUM ION; CALPAIN; CALPASTATIN; CASPASE 3; CELL DNA; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PD 150606; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; EXCITOTOXICITY; FEMALE; FETUS; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; IONIZING RADIATION; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; RADIATION RESPONSE; RAT; RECEPTOR UPREGULATION;

ANIMALS; APOPTOSIS; BRAIN; CALPAIN; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; DIZOCILPINE MALEATE; DNA DAMAGE; GLYCOPROTEINS; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; NEURONS; RADIATION, IONIZING; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84873140715     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1245     Document Type: Article

References (53)

1. Li YQ, Jay V and Wong CS: Oligodendrocytes in the adult rat spinal cord undergo radiation-induced apoptosis. Cancer Res 56: 5417-5422, 1996.
2. Saito S, Aoki I, Sawada K and Suhara T: Quantitative assessment of central nervous system disorder induced by prenatal X-ray exposure using diffusion and manganese-enhanced MRI. NMR Biomed 25: 75-83, 2011.
3. Thabet A, Kalva SP, Liu B, Mueller PR and Lee SI: Interventional radiology in pregnancy complications: indications, technique, and methods for minimizing radiation exposure. Radiographics 32: 255-274, 2012.
4. Otake M and Schull WJ: Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors. Int J Radiat Biol 74: 159-171, 1998.
5. Sudhof TC: Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455: 903-911, 2008.
6. Bassell GJ and Warren ST: Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60: 201-214, 2008.
7. Garcia O, Torres M, Helguera P, Coskun P and Busciglio J: A role for thrombospondin-1 deficits in astrocyte-mediated spine and synaptic pathology in Down's syndrome. PLoS One 5: e14200, 2010.
8. Luo J: GSK3beta in ethanol neurotoxicity. Mol Neurobiol 40: 108-121, 2009.
9. Zecevic N: Synaptogenesis in layer I of the human cerebral cortex in the first half of gestation. Cereb Cortex 8: 245-252, 1998.
10. Balslev Y, Saunders NR and Mollgard K: Synaptogenesis in the neocortical anlage and early developing neocortex of rat embryos. Acta Anat (Basel) 156: 2-10, 1996.
11. Oppenheim RW: Cell death during development of the nervous system. Annu Rev Neurosci 14: 453-501, 1991.
12. Wolvetang EJ, Wilson TJ, Sanij E, et al: ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Hum Mol Genet 12: 247-255, 2003.
13. Okamoto M, Suzuki Y, Shirai K, et al: Effect of radiation on the development of immature hippocampal neurons in vitro. Radiat Res 172: 718-724, 2009.
14. Bolaris S, Bozas E, Benekou A, Philippidis H and Stylianopoulou F: In utero radiation-induced apoptosis and p53 gene expression in the developing rat brain. Int J Radiat Biol 77: 71-81, 2001.
15. Poulaki V, Benekou A, Bozas E, Bolaris S and Stylianopoulou F: p53 expression and regulation by NMDA receptors in the developing rat brain. J Neurosci Res 56: 427-440, 1999.
16. Perez-Otano I and Ehlers MD: Learning from NMDA receptor trafficking: clues to the development and maturation of glutamatergic synapses. Neurosignals 13: 175-189, 2004.
17. Hynd MR, Scott HL and Dodd PR: Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45: 583-595, 2004.
18. Blandini F: An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease. Funct Neurol 25: 65-71, 2010.
19. Lipton SA and Rosenberg PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330: 613-622, 1994.
20. Brorson JR, Marcuccilli CJ and Miller RJ: Delayed antagonism of calpain reduces excitotoxicity in cultured neurons. Stroke 26: 1259-1267, 1995.
21. Alaoui F, Pratt J, Trocherie S, Court L and Stutzmann JM: Acute effects of irradiation on the rat brain: protection by glutamate blockade. Eur J Pharmacol 276: 55-60, 1995.
22. De Vos WH, Van Neste L, Dieriks B, Joss GH and Van Oostveldt P: High content image cytometry in the context of subnuclear organization. Cytometry A 77: 64-75, 2010.
23. Verkhratsky A and Kirchhoff F: NMDA Receptors in glia. Neuroscientist 13: 28-37, 2007.
24. Wallace SS: Enzymatic processing of radiation-induced free radical damage in DNA. Radiat Res 150 (Suppl 5): S60-S79, 1998.
25. Jeggo P and Lavin MF: Cellular radiosensitivity: how much better do we understand it? Int J Radiat Biol 85: 1061-1081, 2009.
26. Chistiakov DA, Voronova NV and Chistiakov PA: Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients. Acta Oncol 47: 809-824, 2008.
27. Kurz EU and Lees-Miller SP: DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 3: 889-900, 2004.
28. Harris CC and Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318-1327, 1993.
29. Verheyde J, de Saint-Georges L, Leyns L and Benotmane MA: The role of Trp53 in the transcriptional response to ionizing radiation in the developing brain. DNA Res 13: 65-75, 2006.
30. Lai CY, Tsai AC, Chen MC, et al: Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo. PLoS One 7: e42192, 2012.
31. Laptenko O and Prives C: Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ 13: 951-961, 2006.
32. Koike T, Yang Y, Suzuki K and Zheng X: Axon and dendrite degeneration: its mechanisms and protective experimental paradigms. Neurochem Int 52: 751-760, 2008.
33. Vosler PS, Gao Y, Brennan CS, et al: Ischemia-induced calpain activation causes eukaryotic (translation) initiation factor 4G1 (eIF4GI) degradation, protein synthesis inhibition, and neuronal death. Proc Natl Acad Sci USA 108: 18102-18107, 2011.
34. Arundine M and Tymianski M: Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34: 325-337, 2003.
35. Waring P: Redox active calcium ion channels and cell death. Arch Biochem Biophys 434: 33-42, 2005.
36. Wroge CM, Hogins J, Eisenman L and Mennerick S: Synaptic NMDA receptors mediate hypoxic excitotoxic death. J Neurosci 32: 6732-6742, 2012.
37. D'Orsi B, Bonner H, Tuffy LP, et al: Calpains are downstream effectors of bax-dependent excitotoxic apoptosis. J Neurosci 32: 1847-1858, 2012.
38. Tenneti L and Lipton SA: Involvement of activated caspase-3-like proteases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem 74: 134-142, 2000.
39. Taylor RC, Cullen SP and Martin SJ: Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241, 2008.
40. Siman R and Noszek JC: Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1: 279-287, 1988.
41. Czogalla A and Sikorski AF: Spectrin and calpain: a 'target' and a 'sniper' in the pathology of neuronal cells. Cell Mol Life Sci 62: 1913-1924, 2005.
42. Bano D, Young KW, Guerin CJ, et al: Cleavage of the plasma membrane Na+/Ca2+ exchanger in excitotoxicity. Cell 120: 275-285, 2005.
43. French JP, Quindry JC, Falk DJ, et al: Ischemia-reperfusion-induced calpain activation and SERCA2a degradation are attenuated by exercise training and calpain inhibition. Am J Physiol Heart Circ Physiol 290: H128-H136, 2006.
44. Wu HY, Tomizawa K, Oda Y, et al: Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem 279: 4929-4940, 2004.
45. Saito Y, Nishio K, Ogawa Y, et al: Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: involvement of hydrogen peroxide-dependent and -independent action. Free Radic Biol Med 42: 675-685, 2007.
46. Boehmerle W and Endres M: Salinomycin induces calpain and cytochrome c-mediated neuronal cell death. Cell Death Dis 2: e168, 2011.
47. Blomgren K, Zhu C, Wang X, et al: Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of 'pathological apoptosis'? J Biol Chem 276: 10191-10198, 2001.
48. McGinnis KM, Gnegy ME, Park YH, Mukerjee N and Wang KK: Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem Biophys Res Commun 263: 94-99, 1999.
49. Komarova EA, Chernov MV, Franks R, et al: Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J 16: 1391-1400, 1997.
50. Morris EJ, Keramaris E, Rideout HJ, et al: Cyclin-dependent kinases and P53 pathways are activated independently and mediate Bax activation in neurons after DNA damage. J Neurosci 21: 5017-5026, 2001.
51. Djebaili M, Rondouin G, Baille V and Bockaert J: p53 and Bax implication in NMDA induced-apoptosis in mouse hippocampus. Neuroreport 11: 2973-2976, 2000.
52. Sedarous M, Keramaris E, O'Hare M, et al: Calpains mediate p53 activation and neuronal death evoked by DNA damage. J Biol Chem 278: 26031-26038, 2003.
53. Hama Y, Katsuki H, Izumi Y, Kume T and Akaike A: Excitotoxicity- associated p53 expression in adult rat retina is mediated by calpain activity but not by Cl- influx. J Pharmacol Sci 110: 493-496, 2009.